GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4g
|
ENSRNOG00000008971 | hepatocyte nuclear factor 4, gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hnf4g | rn6_v1_chr2_-_100372252_100372252 | 0.68 | 3.5e-45 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_123621102 | 134.30 |
ENSRNOT00000046024
|
Cyp2d5
|
cytochrome P450, family 2, subfamily d, polypeptide 5 |
chr16_-_81834945 | 107.28 |
ENSRNOT00000037806
|
F7
|
coagulation factor VII |
chr7_-_123655896 | 101.23 |
ENSRNOT00000012413
|
Cyp2d2
|
cytochrome P450, family 2, subfamily d, polypeptide 2 |
chr1_+_21525421 | 99.12 |
ENSRNOT00000017911
|
Arg1
|
arginase 1 |
chr18_-_35071619 | 94.97 |
ENSRNOT00000075695
|
LOC100911558
|
serine protease inhibitor Kazal-type 3-like |
chr11_-_81660395 | 94.54 |
ENSRNOT00000048739
|
Fetub
|
fetuin B |
chr4_-_30338679 | 93.70 |
ENSRNOT00000012050
|
Pon3
|
paraoxonase 3 |
chr2_-_23256158 | 89.88 |
ENSRNOT00000015336
|
Bhmt
|
betaine-homocysteine S-methyltransferase |
chr11_+_65022100 | 88.05 |
ENSRNOT00000003934
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr9_+_16314173 | 87.20 |
ENSRNOT00000072812
|
LOC100911564
|
glycine N-methyltransferase-like |
chr7_-_123630045 | 86.05 |
ENSRNOT00000050002
|
Cyp2d1
|
cytochrome P450, family 2, subfamily d, polypeptide 1 |
chr4_+_154215250 | 85.23 |
ENSRNOT00000072465
|
Mug2
|
murinoglobulin 2 |
chr1_+_100470722 | 85.05 |
ENSRNOT00000086917
|
Aspdh
|
aspartate dehydrogenase domain containing |
chr10_+_56662242 | 84.64 |
ENSRNOT00000086919
|
Asgr1
|
asialoglycoprotein receptor 1 |
chr11_-_81444375 | 83.41 |
ENSRNOT00000058479
ENSRNOT00000078131 ENSRNOT00000080949 ENSRNOT00000080562 ENSRNOT00000084867 |
Kng1
|
kininogen 1 |
chr1_+_213511874 | 83.28 |
ENSRNOT00000078080
ENSRNOT00000016883 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr2_-_23289266 | 78.42 |
ENSRNOT00000061708
|
Bhmt2
|
betaine-homocysteine S-methyltransferase 2 |
chr7_-_123638702 | 75.49 |
ENSRNOT00000082473
ENSRNOT00000044470 ENSRNOT00000092017 |
Cyp2d1
|
cytochrome P450, family 2, subfamily d, polypeptide 1 |
chr1_+_193424812 | 75.01 |
ENSRNOT00000019939
|
Aqp8
|
aquaporin 8 |
chr17_+_9736786 | 74.56 |
ENSRNOT00000081920
|
F12
|
coagulation factor XII |
chr2_+_20857202 | 74.52 |
ENSRNOT00000078919
|
Acot12
|
acyl-CoA thioesterase 12 |
chr19_+_50246402 | 74.41 |
ENSRNOT00000018795
|
Hsd17b2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
chr10_+_56662561 | 74.24 |
ENSRNOT00000025254
|
Asgr1
|
asialoglycoprotein receptor 1 |
chr7_-_117679219 | 73.52 |
ENSRNOT00000071522
|
Slc39a4
|
solute carrier family 39 member 4 |
chr9_-_4168221 | 72.36 |
ENSRNOT00000061861
|
Sult1c2a
|
sulfotransferase family, cytosolic, 1C, member 2a |
chr3_+_171213936 | 70.58 |
ENSRNOT00000031586
|
Pck1
|
phosphoenolpyruvate carboxykinase 1 |
chr5_+_160306727 | 69.61 |
ENSRNOT00000016648
|
Agmat
|
agmatinase |
chr13_+_89597138 | 69.31 |
ENSRNOT00000004662
|
Apoa2
|
apolipoprotein A2 |
chr1_-_76722965 | 68.98 |
ENSRNOT00000052129
|
LOC100912485
|
alcohol sulfotransferase-like |
chr4_+_99063181 | 67.74 |
ENSRNOT00000008840
|
Fabp1
|
fatty acid binding protein 1 |
chr5_-_134207847 | 67.24 |
ENSRNOT00000083686
ENSRNOT00000088209 ENSRNOT00000051252 |
Cyp4a2
|
cytochrome P450, family 4, subfamily a, polypeptide 2 |
chr1_-_76780230 | 66.96 |
ENSRNOT00000002046
|
LOC100912485
|
alcohol sulfotransferase-like |
chr1_+_282678166 | 65.03 |
ENSRNOT00000045656
|
Ces2c
|
carboxylesterase 2C |
chr8_-_130550388 | 63.19 |
ENSRNOT00000026355
|
Cyp8b1
|
cytochrome P450, family 8, subfamily b, polypeptide 1 |
chr6_-_129010271 | 62.08 |
ENSRNOT00000075378
|
Serpina10
|
serpin family A member 10 |
chr11_-_66034573 | 62.07 |
ENSRNOT00000003645
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr1_-_263803150 | 61.73 |
ENSRNOT00000017840
|
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr9_+_95285592 | 60.99 |
ENSRNOT00000063853
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr5_+_60528997 | 60.88 |
ENSRNOT00000051445
|
Grhpr
|
glyoxylate and hydroxypyruvate reductase |
chr1_-_224533219 | 59.17 |
ENSRNOT00000051289
|
Ust5r
|
integral membrane transport protein UST5r |
chr1_-_80594136 | 58.51 |
ENSRNOT00000024800
|
Apoc2
|
apolipoprotein C2 |
chr5_-_124403195 | 58.34 |
ENSRNOT00000067850
|
C8a
|
complement C8 alpha chain |
chr3_-_127500709 | 58.22 |
ENSRNOT00000006330
|
Hao1
|
hydroxyacid oxidase 1 |
chr12_-_48365784 | 57.51 |
ENSRNOT00000077317
|
Dao
|
D-amino-acid oxidase |
chr15_+_18451144 | 56.31 |
ENSRNOT00000010260
|
Acox2
|
acyl-CoA oxidase 2 |
chr10_+_65767053 | 56.24 |
ENSRNOT00000078897
|
Vtn
|
vitronectin |
chr7_-_117680004 | 55.54 |
ENSRNOT00000040422
|
Slc39a4
|
solute carrier family 39 member 4 |
chr16_+_18736154 | 55.42 |
ENSRNOT00000015723
|
Mbl1
|
mannose-binding lectin (protein A) 1 |
chr8_+_50525091 | 55.40 |
ENSRNOT00000074357
|
Apoa1
|
apolipoprotein A1 |
chr1_+_20856187 | 55.15 |
ENSRNOT00000071726
|
Smlr1
|
small leucine-rich protein 1 |
chr1_+_282640706 | 54.96 |
ENSRNOT00000073241
ENSRNOT00000080995 |
Ces2c
|
carboxylesterase 2C |
chr17_-_43543172 | 54.58 |
ENSRNOT00000080684
ENSRNOT00000029626 ENSRNOT00000082719 |
Slc17a3
|
solute carrier family 17 member 3 |
chrX_+_143097525 | 53.42 |
ENSRNOT00000004559
|
F9
|
coagulation factor IX |
chr2_+_150146234 | 53.01 |
ENSRNOT00000018761
|
Aadac
|
arylacetamide deacetylase |
chr9_-_4945352 | 52.92 |
ENSRNOT00000082530
|
Sult1c3
|
sulfotransferase family 1C member 3 |
chr7_+_140781799 | 52.13 |
ENSRNOT00000087932
|
Dnajc22
|
DnaJ heat shock protein family (Hsp40) member C22 |
chr14_-_86164341 | 51.83 |
ENSRNOT00000086343
ENSRNOT00000080147 |
Gck
|
glucokinase |
chr1_+_219233750 | 51.64 |
ENSRNOT00000024112
|
Acy3
|
aminoacylase 3 |
chr16_-_32868680 | 50.83 |
ENSRNOT00000015974
ENSRNOT00000082392 |
Aadat
|
aminoadipate aminotransferase |
chr19_+_15339152 | 50.78 |
ENSRNOT00000060929
|
Ces1a
|
carboxylesterase 1A |
chr12_-_11733099 | 50.64 |
ENSRNOT00000051244
ENSRNOT00000087257 |
Cyp3a23/3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
chr9_+_95256627 | 50.54 |
ENSRNOT00000025291
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr9_+_95274707 | 50.36 |
ENSRNOT00000045163
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr4_-_115332052 | 50.09 |
ENSRNOT00000017643
|
Clec4f
|
C-type lectin domain family 4, member F |
chr2_+_188449210 | 49.58 |
ENSRNOT00000027700
|
Pklr
|
pyruvate kinase, liver and RBC |
chr1_+_100471066 | 49.27 |
ENSRNOT00000067562
|
Aspdh
|
aspartate dehydrogenase domain containing |
chr9_+_95295701 | 49.14 |
ENSRNOT00000025045
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr16_+_20521956 | 48.53 |
ENSRNOT00000026597
|
Pgpep1
|
pyroglutamyl-peptidase I |
chr5_+_137357674 | 48.48 |
ENSRNOT00000092813
|
RGD1305347
|
similar to RIKEN cDNA 2610528J11 |
chr2_+_181987217 | 48.03 |
ENSRNOT00000034521
|
Fgg
|
fibrinogen gamma chain |
chr8_+_117117430 | 47.85 |
ENSRNOT00000073247
|
Gpx1
|
glutathione peroxidase 1 |
chrX_+_134940615 | 47.36 |
ENSRNOT00000005604
|
Xpnpep2
|
X-prolyl aminopeptidase 2 |
chr9_+_95501778 | 47.06 |
ENSRNOT00000086805
|
Spp2
|
secreted phosphoprotein 2 |
chr10_+_71159869 | 46.66 |
ENSRNOT00000075977
ENSRNOT00000047427 |
Hnf1b
|
HNF1 homeobox B |
chr3_-_150603082 | 46.65 |
ENSRNOT00000024310
|
Ahcy
|
adenosylhomocysteinase |
chr2_-_235052464 | 46.63 |
ENSRNOT00000093512
|
LOC103691699
|
uncharacterized LOC103691699 |
chr13_+_91080341 | 46.34 |
ENSRNOT00000000058
|
Crp
|
C-reactive protein |
chr20_-_12820466 | 46.25 |
ENSRNOT00000001699
|
Ftcd
|
formimidoyltransferase cyclodeaminase |
chr1_-_102013243 | 46.24 |
ENSRNOT00000042115
|
Abcc6
|
ATP binding cassette subfamily C member 6 |
chr11_-_81717521 | 46.02 |
ENSRNOT00000058422
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr6_+_127946686 | 45.86 |
ENSRNOT00000082680
|
LOC500712
|
Ab1-233 |
chr1_+_251145253 | 45.79 |
ENSRNOT00000083555
ENSRNOT00000014979 |
Papss2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr15_+_34155504 | 45.73 |
ENSRNOT00000024782
|
Dhrs4
|
dehydrogenase/reductase 4 |
chr13_-_50499060 | 45.73 |
ENSRNOT00000065347
ENSRNOT00000076924 |
Etnk2
|
ethanolamine kinase 2 |
chr6_-_127620296 | 45.67 |
ENSRNOT00000012577
|
Serpina1
|
serpin family A member 1 |
chr12_+_47407811 | 45.66 |
ENSRNOT00000001565
|
Hnf1a
|
HNF1 homeobox A |
chr18_+_59830363 | 45.45 |
ENSRNOT00000082650
ENSRNOT00000078378 |
Onecut2
|
one cut domain, family member 2 |
chr16_+_6970342 | 45.14 |
ENSRNOT00000061294
ENSRNOT00000048344 |
Itih4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr4_-_30276372 | 45.13 |
ENSRNOT00000011823
|
Pon1
|
paraoxonase 1 |
chr1_+_16910069 | 44.59 |
ENSRNOT00000020015
|
Aldh8a1
|
aldehyde dehydrogenase 8 family, member A1 |
chr17_-_32076181 | 44.44 |
ENSRNOT00000074842
|
LOC100911107
|
leukocyte elastase inhibitor A-like |
chr1_-_224389389 | 44.37 |
ENSRNOT00000077408
ENSRNOT00000050010 |
UST4r
|
integral membrane transport protein UST4r |
chr2_+_60337667 | 44.13 |
ENSRNOT00000024035
|
Agxt2
|
alanine-glyoxylate aminotransferase 2 |
chr14_+_87448692 | 43.95 |
ENSRNOT00000077177
|
Igfbp1
|
insulin-like growth factor binding protein 1 |
chr3_-_10371240 | 43.84 |
ENSRNOT00000012075
|
Ass1
|
argininosuccinate synthase 1 |
chr1_-_76614279 | 43.53 |
ENSRNOT00000041367
ENSRNOT00000089371 |
LOC100912485
|
alcohol sulfotransferase-like |
chr2_+_55775274 | 43.07 |
ENSRNOT00000018545
|
C9
|
complement C9 |
chr1_+_83744238 | 42.75 |
ENSRNOT00000028249
|
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr16_+_74534130 | 42.61 |
ENSRNOT00000050637
|
Slc25a15
|
solute carrier family 25 member 15 |
chr1_-_258766881 | 42.26 |
ENSRNOT00000015801
|
Cyp2c12
|
cytochrome P450, family 2, subfamily c, polypeptide 12 |
chr20_-_4542073 | 42.18 |
ENSRNOT00000000477
|
Cfb
|
complement factor B |
chr17_+_30617382 | 42.04 |
ENSRNOT00000048923
|
Eci2
|
enoyl-CoA delta isomerase 2 |
chr5_+_157801163 | 41.96 |
ENSRNOT00000024160
|
Akr7a3
|
aldo-keto reductase family 7 member A3 |
chr7_+_70980422 | 41.37 |
ENSRNOT00000077912
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr7_+_71065197 | 41.31 |
ENSRNOT00000051075
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr3_-_101465995 | 40.90 |
ENSRNOT00000080175
|
Bbox1
|
gamma-butyrobetaine hydroxylase 1 |
chr5_-_78985990 | 40.87 |
ENSRNOT00000009248
|
Ambp
|
alpha-1-microglobulin/bikunin precursor |
chr2_+_23289374 | 40.50 |
ENSRNOT00000090666
ENSRNOT00000032783 |
Dmgdh
|
dimethylglycine dehydrogenase |
chr4_-_176679815 | 40.49 |
ENSRNOT00000090122
|
Gys2
|
glycogen synthase 2 |
chr7_-_2677199 | 40.34 |
ENSRNOT00000043908
|
Apon
|
apolipoprotein N |
chr1_+_83103925 | 40.28 |
ENSRNOT00000047540
ENSRNOT00000028196 |
Cyp2b2
|
cytochrome P450, family 2, subfamily b, polypeptide 2 |
chr1_-_224698514 | 40.26 |
ENSRNOT00000024234
|
Slc22a25
|
solute carrier family 22, member 25 |
chr18_-_28428117 | 40.10 |
ENSRNOT00000078202
|
Slc23a1
|
solute carrier family 23 member 1 |
chr1_-_219311502 | 40.06 |
ENSRNOT00000085439
|
RGD1307603
|
similar to hypothetical protein MGC37914 |
chr9_+_9721105 | 39.68 |
ENSRNOT00000073042
ENSRNOT00000075494 |
C3
|
complement C3 |
chr5_+_79179417 | 39.62 |
ENSRNOT00000010454
|
Orm1
|
orosomucoid 1 |
chr9_-_15582556 | 39.48 |
ENSRNOT00000020516
|
RGD1561662
|
similar to AI661453 protein |
chr7_-_3386522 | 39.45 |
ENSRNOT00000010760
|
Mettl7b
|
methyltransferase like 7B |
chr6_-_127508452 | 39.35 |
ENSRNOT00000073709
|
LOC100909524
|
protein Z-dependent protease inhibitor-like |
chr4_+_157126935 | 39.24 |
ENSRNOT00000056051
|
C1r
|
complement C1r |
chrX_-_1848904 | 39.17 |
ENSRNOT00000010984
|
Rgn
|
regucalcin |
chr1_+_81456984 | 38.94 |
ENSRNOT00000027075
|
Ethe1
|
ETHE1, persulfide dioxygenase |
chr2_+_211546560 | 38.79 |
ENSRNOT00000033443
|
Aknad1
|
AKNA domain containing 1 |
chr4_-_82702429 | 38.53 |
ENSRNOT00000011069
|
Hibadh
|
3-hydroxyisobutyrate dehydrogenase |
chr10_+_109708755 | 38.51 |
ENSRNOT00000083601
|
Gcgr
|
glucagon receptor |
chr6_+_128050250 | 38.41 |
ENSRNOT00000077517
ENSRNOT00000013961 |
LOC500712
|
Ab1-233 |
chr1_-_259287684 | 38.32 |
ENSRNOT00000054724
|
Cyp2c22
|
cytochrome P450, family 2, subfamily c, polypeptide 22 |
chr17_-_69827112 | 38.29 |
ENSRNOT00000023835
|
Akr1c14
|
aldo-keto reductase family 1, member C14 |
chr1_+_48273611 | 38.27 |
ENSRNOT00000022254
ENSRNOT00000022068 |
Slc22a1
|
solute carrier family 22 member 1 |
chr15_-_34444244 | 37.66 |
ENSRNOT00000027612
|
Cideb
|
cell death-inducing DFFA-like effector b |
chr1_+_147713892 | 37.57 |
ENSRNOT00000092985
ENSRNOT00000054742 ENSRNOT00000074103 |
Cyp2c6v1
|
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
chr6_-_104631355 | 37.53 |
ENSRNOT00000007825
|
Slc10a1
|
solute carrier family 10 member 1 |
chr1_+_36320461 | 37.52 |
ENSRNOT00000023659
|
Srd5a1
|
steroid 5 alpha-reductase 1 |
chr13_-_47397890 | 37.31 |
ENSRNOT00000005505
|
C4bpb
|
complement component 4 binding protein, beta |
chr13_+_99335020 | 37.27 |
ENSRNOT00000029787
|
AABR07021930.1
|
|
chr17_-_9762813 | 36.64 |
ENSRNOT00000033749
|
Slc34a1
|
solute carrier family 34 member 1 |
chr9_+_16565225 | 36.62 |
ENSRNOT00000022307
|
Gnmt
|
glycine N-methyltransferase |
chrX_+_111122552 | 36.60 |
ENSRNOT00000083566
ENSRNOT00000085078 ENSRNOT00000090928 |
Cldn2
|
claudin 2 |
chr11_+_61609370 | 36.47 |
ENSRNOT00000088880
ENSRNOT00000082533 |
Gramd1c
|
GRAM domain containing 1C |
chr7_+_99158119 | 36.32 |
ENSRNOT00000044127
|
LOC108348266
|
cytochrome P450 2B1 |
chr1_+_40086470 | 36.31 |
ENSRNOT00000021895
|
Iyd
|
iodotyrosine deiodinase |
chr13_+_82479998 | 36.21 |
ENSRNOT00000079872
|
F5
|
coagulation factor V |
chr1_-_101596822 | 35.86 |
ENSRNOT00000028490
|
Fgf21
|
fibroblast growth factor 21 |
chr18_-_28425944 | 35.62 |
ENSRNOT00000084372
|
Slc23a1
|
solute carrier family 23 member 1 |
chr3_-_4055806 | 35.61 |
ENSRNOT00000026408
|
Agpat2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr13_+_93684437 | 35.43 |
ENSRNOT00000005005
|
Kmo
|
kynurenine 3-monooxygenase |
chr14_+_22806132 | 35.40 |
ENSRNOT00000002728
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr13_-_56763981 | 35.38 |
ENSRNOT00000087916
|
LOC100361907
|
complement factor H-related protein B |
chr19_+_42097995 | 35.33 |
ENSRNOT00000020197
|
Hp
|
haptoglobin |
chr8_-_27852996 | 35.22 |
ENSRNOT00000037790
|
Glb1l2
|
galactosidase, beta 1-like 2 |
chr2_+_53109684 | 35.16 |
ENSRNOT00000086590
|
Selenop
|
selenoprotein P |
chr1_-_221917901 | 34.95 |
ENSRNOT00000092270
|
Slc22a12
|
solute carrier family 22 member 12 |
chr13_+_44424689 | 34.86 |
ENSRNOT00000005206
|
Acmsd
|
aminocarboxymuconate semialdehyde decarboxylase |
chr14_+_7113544 | 34.56 |
ENSRNOT00000038188
|
Hsd17b13
|
hydroxysteroid (17-beta) dehydrogenase 13 |
chr3_-_5802129 | 34.48 |
ENSRNOT00000009555
|
Sardh
|
sarcosine dehydrogenase |
chr1_+_83163079 | 34.41 |
ENSRNOT00000077725
ENSRNOT00000034845 |
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3 |
chr5_-_78285451 | 34.33 |
ENSRNOT00000019924
|
Rnf183
|
ring finger protein 183 |
chr1_-_76517134 | 34.27 |
ENSRNOT00000064593
ENSRNOT00000085775 |
LOC100912485
|
alcohol sulfotransferase-like |
chr13_+_75175254 | 34.17 |
ENSRNOT00000044008
|
Sec16b
|
SEC16 homolog B, endoplasmic reticulum export factor |
chr19_+_15294248 | 34.10 |
ENSRNOT00000024622
|
Ces1f
|
carboxylesterase 1F |
chr12_+_9446940 | 34.08 |
ENSRNOT00000074791
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase |
chr9_+_15582564 | 33.96 |
ENSRNOT00000020640
|
LOC100912849
|
uncharacterized LOC100912849 |
chr16_-_81822716 | 33.90 |
ENSRNOT00000026677
|
F10
|
coagulation factor X |
chr14_+_99919485 | 33.54 |
ENSRNOT00000006087
|
Egfr
|
epidermal growth factor receptor |
chr6_+_33176778 | 33.46 |
ENSRNOT00000046811
ENSRNOT00000007371 |
Apob
|
apolipoprotein B |
chr8_-_111777602 | 33.19 |
ENSRNOT00000052317
ENSRNOT00000083855 |
RGD1310507
|
similar to RIKEN cDNA 1300017J02 |
chr17_-_8607494 | 33.02 |
ENSRNOT00000016138
|
Slc25a48
|
solute carrier family 25, member 48 |
chr1_-_198559568 | 32.91 |
ENSRNOT00000023080
|
Qprt
|
quinolinate phosphoribosyltransferase |
chr1_-_146289465 | 32.82 |
ENSRNOT00000017362
|
Abhd17c
|
abhydrolase domain containing 17C |
chr12_-_21832813 | 32.79 |
ENSRNOT00000075280
|
Cldn3
|
claudin 3 |
chr15_-_42693694 | 32.62 |
ENSRNOT00000022702
|
Gulo
|
gulonolactone (L-) oxidase |
chr10_+_56710965 | 32.55 |
ENSRNOT00000087121
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr7_+_14891001 | 32.36 |
ENSRNOT00000041034
|
Cyp4f4
|
cytochrome P450, family 4, subfamily f, polypeptide 4 |
chr15_-_3650819 | 32.30 |
ENSRNOT00000014273
|
Plau
|
plasminogen activator, urokinase |
chr14_+_17195014 | 32.24 |
ENSRNOT00000031667
|
Cxcl11
|
C-X-C motif chemokine ligand 11 |
chr9_-_4978892 | 32.09 |
ENSRNOT00000015189
|
Sult1c3
|
sulfotransferase family 1C member 3 |
chr18_-_15225427 | 31.96 |
ENSRNOT00000090853
|
Rnf125
|
ring finger protein 125 |
chr16_-_21099878 | 31.88 |
ENSRNOT00000027800
|
Tm6sf2
|
transmembrane 6 superfamily member 2 |
chr9_-_26707571 | 31.60 |
ENSRNOT00000080948
|
AABR07067023.1
|
|
chr10_+_50928309 | 31.58 |
ENSRNOT00000033737
|
Hs3st3a1
|
heparan sulfate-glucosamine 3-sulfotransferase 3A1 |
chr14_+_77079402 | 31.55 |
ENSRNOT00000042200
|
Slc2a9
|
solute carrier family 2 member 9 |
chr10_-_70802782 | 31.28 |
ENSRNOT00000045867
|
Ccl6
|
chemokine (C-C motif) ligand 6 |
chr13_-_99287887 | 31.21 |
ENSRNOT00000004780
|
Ephx1
|
epoxide hydrolase 1 |
chr13_-_37287458 | 31.03 |
ENSRNOT00000003391
|
Insig2
|
insulin induced gene 2 |
chr13_+_78812394 | 30.88 |
ENSRNOT00000076043
|
Serpinc1
|
serpin family C member 1 |
chr17_+_69588085 | 30.55 |
ENSRNOT00000064884
|
Akr1c12l1
|
aldo-keto reductase family 1, member C12-like 1 |
chr2_+_182006242 | 30.55 |
ENSRNOT00000064091
|
Fga
|
fibrinogen alpha chain |
chrX_+_15669191 | 30.55 |
ENSRNOT00000013553
|
Magix
|
MAGI family member, X-linked |
chr8_+_71914867 | 30.49 |
ENSRNOT00000023372
|
Dapk2
|
death-associated protein kinase 2 |
chr7_-_119689938 | 30.35 |
ENSRNOT00000000200
|
Tmprss6
|
transmembrane protease, serine 6 |
chr4_-_122237754 | 30.34 |
ENSRNOT00000029915
|
Chst13
|
carbohydrate sulfotransferase 13 |
chr19_-_64303 | 30.10 |
ENSRNOT00000015451
|
Ces2a
|
carboxylesterase 2A |
chr8_-_22937909 | 29.85 |
ENSRNOT00000015684
|
Tmem205
|
transmembrane protein 205 |
chr13_+_97702097 | 29.83 |
ENSRNOT00000057787
|
LOC103689999
|
saccharopine dehydrogenase-like oxidoreductase |
chr10_+_86399827 | 29.80 |
ENSRNOT00000009299
|
Grb7
|
growth factor receptor bound protein 7 |
chr1_-_199377035 | 29.70 |
ENSRNOT00000026572
|
Prss8
|
protease, serine, 8 |
chr2_+_93669765 | 29.64 |
ENSRNOT00000045438
|
Slc10a5
|
solute carrier family 10, member 5 |
chr20_-_28263037 | 29.45 |
ENSRNOT00000030348
|
Edar
|
ectodysplasin-A receptor |
chr3_-_5976244 | 29.45 |
ENSRNOT00000009893
|
Vav2
|
vav guanine nucleotide exchange factor 2 |
chr1_-_261986759 | 29.37 |
ENSRNOT00000021257
|
Pyroxd2
|
pyridine nucleotide-disulphide oxidoreductase domain 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
44.8 | 134.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
43.5 | 130.4 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
43.0 | 129.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
41.6 | 83.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
41.6 | 124.7 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
36.8 | 110.4 | GO:1904612 | response to 2,3,7,8-tetrachlorodibenzodioxine(GO:1904612) |
34.0 | 102.1 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
29.1 | 116.2 | GO:0006562 | proline catabolic process(GO:0006562) |
28.3 | 113.2 | GO:0035565 | regulation of pronephros size(GO:0035565) |
26.8 | 321.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
26.4 | 158.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
25.2 | 75.7 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
24.4 | 73.2 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) |
23.4 | 211.0 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
22.8 | 68.5 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) formamide metabolic process(GO:0043606) |
22.6 | 67.7 | GO:0051977 | lysophospholipid transport(GO:0051977) |
22.3 | 111.6 | GO:1904640 | response to methionine(GO:1904640) |
21.4 | 171.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
20.3 | 81.0 | GO:0006554 | lysine catabolic process(GO:0006554) L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
19.8 | 99.1 | GO:1902023 | regulation of amino acid import(GO:0010958) L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
19.5 | 58.5 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
19.4 | 77.7 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
19.4 | 174.2 | GO:0015747 | urate transport(GO:0015747) |
18.8 | 75.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
18.8 | 56.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
18.7 | 37.3 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
18.6 | 92.9 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
17.3 | 51.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
17.2 | 103.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
15.9 | 47.8 | GO:0009609 | response to symbiotic bacterium(GO:0009609) |
15.5 | 46.6 | GO:0097187 | dentinogenesis(GO:0097187) |
15.2 | 45.7 | GO:0033986 | response to methanol(GO:0033986) |
15.0 | 45.1 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
14.8 | 14.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
14.6 | 43.8 | GO:0000053 | argininosuccinate metabolic process(GO:0000053) |
14.6 | 58.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
14.0 | 42.0 | GO:1901377 | toxin catabolic process(GO:0009407) mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) secondary metabolite catabolic process(GO:0090487) organic heteropentacyclic compound catabolic process(GO:1901377) |
13.9 | 69.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
13.7 | 41.0 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
13.5 | 94.7 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
13.5 | 148.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
13.2 | 105.3 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
13.1 | 52.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
12.9 | 38.7 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
12.8 | 38.5 | GO:0006574 | valine catabolic process(GO:0006574) |
12.5 | 37.6 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
12.5 | 74.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
12.1 | 145.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
11.6 | 186.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
10.9 | 250.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
10.8 | 32.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
10.7 | 75.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
10.6 | 53.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
10.4 | 51.8 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
9.9 | 29.8 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
9.6 | 28.8 | GO:0046865 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
9.6 | 9.6 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
8.8 | 26.5 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
8.7 | 26.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
8.6 | 25.8 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
8.6 | 68.9 | GO:0033590 | response to cobalamin(GO:0033590) |
8.5 | 25.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
8.4 | 75.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
8.3 | 116.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
8.3 | 257.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
8.0 | 40.2 | GO:0015793 | glycerol transport(GO:0015793) |
7.6 | 75.8 | GO:0070989 | oxidative demethylation(GO:0070989) |
7.5 | 52.4 | GO:0006534 | cysteine metabolic process(GO:0006534) |
7.4 | 7.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
7.3 | 14.5 | GO:0003285 | septum secundum development(GO:0003285) |
7.0 | 56.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
7.0 | 20.9 | GO:1903116 | gastrin-induced gastric acid secretion(GO:0001698) positive regulation of actin filament-based movement(GO:1903116) |
6.9 | 34.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
6.9 | 20.6 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
6.8 | 27.3 | GO:0015879 | carnitine transport(GO:0015879) |
6.6 | 26.2 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
6.5 | 52.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
6.5 | 13.0 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
6.5 | 38.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
6.4 | 38.3 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
6.3 | 12.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
6.3 | 25.1 | GO:0051958 | methotrexate transport(GO:0051958) |
6.2 | 12.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
6.1 | 18.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
6.0 | 24.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
6.0 | 12.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
6.0 | 48.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
6.0 | 24.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
6.0 | 95.3 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
5.9 | 17.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
5.9 | 17.7 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
5.8 | 17.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
5.8 | 23.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
5.7 | 28.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
5.7 | 34.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
5.7 | 22.8 | GO:0033231 | carbohydrate export(GO:0033231) daunorubicin transport(GO:0043215) response to borneol(GO:1905230) cellular response to borneol(GO:1905231) response to codeine(GO:1905233) response to quercetin(GO:1905235) drug transport across blood-brain barrier(GO:1990962) establishment of blood-retinal barrier(GO:1990963) |
5.7 | 11.4 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
5.7 | 62.5 | GO:0051132 | NK T cell activation(GO:0051132) |
5.7 | 39.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
5.6 | 16.9 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
5.6 | 16.8 | GO:1990402 | embryonic liver development(GO:1990402) |
5.5 | 11.0 | GO:0006833 | water transport(GO:0006833) |
5.4 | 16.1 | GO:0046687 | response to chromate(GO:0046687) |
5.3 | 10.6 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
5.3 | 31.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
5.3 | 15.9 | GO:0090187 | pancreatic amylase secretion(GO:0036395) positive regulation of pancreatic juice secretion(GO:0090187) regulation of pancreatic amylase secretion(GO:1902276) positive regulation of histamine secretion by mast cell(GO:1903595) |
5.3 | 37.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
5.3 | 47.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
5.2 | 15.7 | GO:1904823 | purine nucleobase transmembrane transport(GO:1904823) |
5.2 | 21.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
5.2 | 20.9 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
5.2 | 20.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
5.1 | 10.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
5.1 | 25.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
5.1 | 15.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
5.0 | 20.0 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
5.0 | 123.9 | GO:0006956 | complement activation(GO:0006956) |
4.9 | 14.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
4.9 | 19.6 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
4.8 | 87.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
4.8 | 14.3 | GO:0045751 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) regulation of Toll signaling pathway(GO:0008592) negative regulation of Toll signaling pathway(GO:0045751) |
4.7 | 19.0 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
4.7 | 33.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
4.7 | 14.2 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
4.7 | 14.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
4.7 | 51.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
4.7 | 18.7 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
4.7 | 18.6 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
4.7 | 214.2 | GO:0006953 | acute-phase response(GO:0006953) |
4.6 | 13.8 | GO:0046356 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
4.6 | 36.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
4.6 | 22.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.5 | 13.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
4.4 | 31.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
4.4 | 17.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
4.4 | 52.7 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
4.4 | 13.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
4.3 | 12.9 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
4.3 | 34.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
4.3 | 8.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
4.2 | 42.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
4.2 | 12.5 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) |
4.1 | 36.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
4.0 | 44.3 | GO:0046415 | urate metabolic process(GO:0046415) |
4.0 | 8.0 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
4.0 | 12.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
4.0 | 44.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
4.0 | 11.9 | GO:0009758 | carbohydrate utilization(GO:0009758) |
4.0 | 11.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
3.9 | 15.8 | GO:0042436 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
3.9 | 23.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
3.9 | 3.9 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
3.8 | 11.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
3.8 | 15.3 | GO:1902896 | terminal web assembly(GO:1902896) |
3.8 | 11.5 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
3.7 | 14.9 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
3.7 | 11.1 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) lipid transport across blood brain barrier(GO:1990379) |
3.7 | 25.7 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
3.6 | 25.3 | GO:0006477 | protein sulfation(GO:0006477) |
3.6 | 7.2 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
3.6 | 10.7 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
3.5 | 21.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
3.5 | 3.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
3.5 | 7.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
3.5 | 7.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
3.5 | 10.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
3.5 | 10.4 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
3.4 | 31.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
3.4 | 27.6 | GO:0034312 | diol biosynthetic process(GO:0034312) |
3.4 | 75.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
3.4 | 13.5 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
3.4 | 16.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
3.3 | 10.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
3.3 | 9.9 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
3.3 | 19.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
3.3 | 9.8 | GO:0061744 | motor behavior(GO:0061744) |
3.3 | 26.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
3.3 | 9.8 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
3.2 | 13.0 | GO:1990839 | response to endothelin(GO:1990839) cellular response to endothelin(GO:1990859) |
3.2 | 35.7 | GO:0097264 | self proteolysis(GO:0097264) |
3.2 | 6.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
3.2 | 9.7 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
3.2 | 9.6 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
3.2 | 9.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
3.2 | 6.4 | GO:0015746 | citrate transport(GO:0015746) |
3.1 | 6.3 | GO:0071681 | cellular response to indole-3-methanol(GO:0071681) |
3.1 | 15.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.1 | 15.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
3.1 | 12.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
3.1 | 33.8 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
3.1 | 12.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
3.1 | 12.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
3.0 | 12.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
3.0 | 39.1 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
3.0 | 8.9 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
3.0 | 5.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.0 | 14.8 | GO:0015889 | cobalamin transport(GO:0015889) |
2.9 | 5.9 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
2.9 | 2.9 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
2.9 | 11.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.9 | 8.8 | GO:1903769 | negative regulation of cell proliferation in bone marrow(GO:1903769) |
2.9 | 17.5 | GO:0070541 | response to platinum ion(GO:0070541) |
2.9 | 17.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
2.9 | 11.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
2.8 | 8.4 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
2.8 | 8.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.8 | 8.3 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
2.7 | 5.4 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
2.7 | 16.1 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
2.7 | 8.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
2.7 | 13.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.7 | 8.0 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
2.7 | 8.0 | GO:0032679 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
2.7 | 5.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.6 | 42.2 | GO:0071872 | cellular response to epinephrine stimulus(GO:0071872) |
2.6 | 34.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
2.6 | 13.1 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
2.6 | 5.2 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
2.6 | 17.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
2.6 | 5.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
2.5 | 7.6 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
2.5 | 7.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
2.5 | 115.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
2.5 | 24.9 | GO:0002934 | desmosome organization(GO:0002934) |
2.5 | 7.4 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
2.5 | 83.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
2.4 | 41.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
2.4 | 7.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
2.4 | 12.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
2.4 | 9.5 | GO:0003383 | apical constriction(GO:0003383) |
2.4 | 7.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
2.4 | 9.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.4 | 4.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.4 | 2.4 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
2.4 | 28.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.4 | 9.4 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
2.3 | 50.9 | GO:0008206 | bile acid metabolic process(GO:0008206) |
2.3 | 6.9 | GO:0048382 | dorsal/ventral axon guidance(GO:0033563) mesendoderm development(GO:0048382) |
2.3 | 13.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
2.3 | 6.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
2.3 | 29.8 | GO:0034063 | stress granule assembly(GO:0034063) |
2.3 | 6.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
2.3 | 27.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
2.2 | 6.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
2.2 | 26.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
2.2 | 15.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
2.2 | 6.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.2 | 8.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
2.2 | 6.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.2 | 21.9 | GO:0070633 | transepithelial transport(GO:0070633) |
2.2 | 10.9 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
2.2 | 10.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
2.2 | 6.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
2.2 | 21.5 | GO:0045056 | transcytosis(GO:0045056) |
2.1 | 15.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
2.1 | 14.7 | GO:0072506 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
2.1 | 8.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
2.1 | 4.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
2.1 | 8.3 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
2.1 | 6.2 | GO:0002604 | regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
2.0 | 18.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
2.0 | 8.1 | GO:0015884 | folic acid transport(GO:0015884) |
2.0 | 6.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
2.0 | 6.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
1.9 | 13.5 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
1.9 | 5.8 | GO:0035973 | aggrephagy(GO:0035973) |
1.9 | 15.4 | GO:0060056 | mammary gland involution(GO:0060056) |
1.9 | 3.8 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.9 | 5.7 | GO:0010037 | response to carbon dioxide(GO:0010037) |
1.9 | 3.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.9 | 5.7 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.9 | 11.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.9 | 11.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.9 | 11.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.8 | 20.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.8 | 11.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
1.8 | 12.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
1.8 | 1.8 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
1.8 | 7.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.8 | 7.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
1.8 | 42.9 | GO:0001523 | retinoid metabolic process(GO:0001523) |
1.8 | 23.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
1.8 | 22.9 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.8 | 5.3 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.8 | 26.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.7 | 10.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.7 | 24.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.7 | 5.2 | GO:0080144 | amino acid homeostasis(GO:0080144) |
1.7 | 5.2 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
1.7 | 6.9 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.7 | 5.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
1.7 | 18.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.7 | 3.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.7 | 23.8 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.7 | 11.9 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
1.7 | 6.7 | GO:1990164 | DNA damage response, detection of DNA damage(GO:0042769) histone H2A phosphorylation(GO:1990164) |
1.7 | 3.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.7 | 36.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
1.7 | 5.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.7 | 6.6 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
1.7 | 5.0 | GO:0070295 | renal water absorption(GO:0070295) |
1.6 | 4.8 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
1.6 | 4.8 | GO:0097298 | regulation of nucleus size(GO:0097298) |
1.6 | 22.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.6 | 4.8 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
1.6 | 39.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
1.5 | 7.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.5 | 18.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.5 | 24.5 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
1.5 | 7.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.5 | 12.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
1.5 | 3.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.5 | 4.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.5 | 4.4 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.5 | 16.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.5 | 10.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.4 | 15.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.4 | 18.5 | GO:0006491 | N-glycan processing(GO:0006491) |
1.4 | 11.2 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
1.4 | 1.4 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
1.4 | 5.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.4 | 4.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.4 | 2.7 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
1.4 | 5.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
1.4 | 4.1 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
1.4 | 8.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.3 | 13.5 | GO:0016266 | O-glycan processing(GO:0016266) |
1.3 | 4.0 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.3 | 4.0 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.3 | 9.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.3 | 5.3 | GO:0007525 | somatic muscle development(GO:0007525) |
1.3 | 4.0 | GO:0060214 | endocardium formation(GO:0060214) |
1.3 | 5.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.3 | 5.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.3 | 3.9 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
1.3 | 16.7 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.3 | 3.8 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
1.3 | 3.8 | GO:0016240 | autophagosome docking(GO:0016240) |
1.3 | 6.4 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
1.3 | 3.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.3 | 7.5 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
1.3 | 3.8 | GO:1904313 | response to methamphetamine hydrochloride(GO:1904313) |
1.3 | 6.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.2 | 3.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.2 | 3.7 | GO:0006116 | NADH oxidation(GO:0006116) |
1.2 | 16.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.2 | 8.4 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
1.2 | 2.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.2 | 9.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.2 | 4.7 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.2 | 2.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.2 | 7.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.2 | 10.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.2 | 13.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
1.1 | 2.3 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
1.1 | 3.4 | GO:0060488 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.1 | 17.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
1.1 | 6.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.1 | 2.3 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.1 | 5.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.1 | 10.1 | GO:0098880 | maintenance of postsynaptic specialization structure(GO:0098880) maintenance of postsynaptic density structure(GO:0099562) |
1.1 | 18.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
1.1 | 3.3 | GO:1990401 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling(GO:0060683) embryonic lung development(GO:1990401) |
1.1 | 6.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.1 | 5.4 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
1.1 | 2.2 | GO:0030824 | negative regulation of cGMP metabolic process(GO:0030824) |
1.1 | 15.1 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
1.1 | 5.4 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.1 | 64.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.1 | 5.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.1 | 8.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.1 | 2.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.1 | 4.2 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
1.0 | 5.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
1.0 | 6.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.0 | 7.3 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
1.0 | 13.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.0 | 7.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.0 | 4.1 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.0 | 3.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.0 | 8.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.0 | 7.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.0 | 2.0 | GO:0036023 | embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.0 | 2.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.0 | 36.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.0 | 4.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.0 | 6.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
1.0 | 7.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
1.0 | 4.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
1.0 | 2.9 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.0 | 141.6 | GO:0007596 | blood coagulation(GO:0007596) |
1.0 | 3.8 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.0 | 4.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.0 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.9 | 4.7 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) |
0.9 | 16.9 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.9 | 6.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.9 | 19.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.9 | 26.1 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.9 | 3.7 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.9 | 3.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.9 | 3.7 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.9 | 12.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.9 | 1.8 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.9 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.9 | 19.0 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.9 | 9.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.9 | 25.2 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.9 | 9.0 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.9 | 3.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.9 | 10.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.9 | 0.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.9 | 2.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.9 | 31.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.9 | 13.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.9 | 3.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.9 | 3.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.9 | 1.7 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.8 | 12.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.8 | 5.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.8 | 2.5 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.8 | 16.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.8 | 6.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.8 | 6.5 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 7.3 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.8 | 7.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.8 | 7.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.8 | 9.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.8 | 10.3 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.8 | 4.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.8 | 1.6 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.8 | 3.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.8 | 3.9 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.8 | 5.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.8 | 4.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.8 | 1.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.8 | 10.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.8 | 13.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.8 | 3.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.7 | 20.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.7 | 2.9 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.7 | 6.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.7 | 2.2 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.7 | 4.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.7 | 2.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.7 | 6.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.7 | 3.5 | GO:0045006 | DNA deamination(GO:0045006) |
0.7 | 17.4 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.7 | 4.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 6.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.7 | 24.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.7 | 22.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.7 | 2.0 | GO:2000195 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) negative regulation of female gonad development(GO:2000195) |
0.7 | 2.0 | GO:1903413 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
0.7 | 0.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.7 | 3.9 | GO:0060023 | hard palate development(GO:0060022) soft palate development(GO:0060023) |
0.6 | 6.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.6 | 6.4 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.6 | 10.9 | GO:0070166 | enamel mineralization(GO:0070166) |
0.6 | 3.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.6 | 4.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 6.9 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.6 | 2.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 5.0 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.6 | 4.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.6 | 3.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.6 | 12.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.6 | 3.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.6 | 3.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.6 | 1.8 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine to uridine editing(GO:0016554) cytidine metabolic process(GO:0046087) |
0.6 | 6.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 1.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.6 | 10.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.6 | 8.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.6 | 2.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.6 | 4.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 1.7 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.6 | 1.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.6 | 3.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.6 | 50.5 | GO:0007586 | digestion(GO:0007586) |
0.6 | 1.7 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.6 | 3.9 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.6 | 1.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.6 | 3.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.6 | 5.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 4.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 3.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 10.9 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.5 | 8.3 | GO:0019835 | cytolysis(GO:0019835) |
0.5 | 2.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.5 | 4.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 5.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.5 | 4.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 3.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.5 | 2.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.5 | 2.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) |
0.5 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 4.5 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.5 | 1.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 3.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 1.0 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.5 | 2.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.5 | 10.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 1.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.5 | 1.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.5 | 4.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 4.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.5 | 4.2 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 4.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.5 | 2.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.5 | 0.9 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.5 | 0.9 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.5 | 2.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 6.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.5 | 1.4 | GO:1903406 | positive regulation of synaptic growth at neuromuscular junction(GO:0045887) regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) regulation of protein geranylgeranylation(GO:2000539) positive regulation of protein geranylgeranylation(GO:2000541) |
0.5 | 2.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.5 | 1.8 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.5 | 4.1 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.5 | 3.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 2.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 2.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.4 | 24.2 | GO:0043648 | dicarboxylic acid metabolic process(GO:0043648) |
0.4 | 1.7 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.4 | 4.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 5.6 | GO:0046931 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.4 | 1.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 3.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 11.8 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.4 | 0.8 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 22.0 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.4 | 6.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.4 | 4.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.4 | 1.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 0.8 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) actin filament bundle distribution(GO:0070650) |
0.4 | 21.2 | GO:0046849 | bone remodeling(GO:0046849) |
0.4 | 1.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.4 | 11.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 2.7 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.4 | 2.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 7.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.4 | 8.9 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.4 | 4.0 | GO:0042407 | cristae formation(GO:0042407) |
0.4 | 3.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.4 | 6.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.4 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 2.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.3 | 0.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.3 | 1.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 6.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 3.4 | GO:0072678 | T cell migration(GO:0072678) |
0.3 | 2.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 2.7 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 6.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.3 | 5.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 4.4 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) regulation of cGMP biosynthetic process(GO:0030826) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 1.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 2.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 1.3 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 6.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 3.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 2.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 3.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 3.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 2.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 2.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 1.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 2.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 5.0 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.3 | 0.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 0.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.3 | 0.5 | GO:1903918 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
0.3 | 2.9 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.3 | 2.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.3 | 34.9 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.3 | 8.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 10.1 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.3 | 1.3 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.3 | 3.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 4.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 2.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.7 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 1.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 10.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.7 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.2 | 2.6 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 123.1 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.2 | 0.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.2 | 5.9 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.9 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.2 | 0.9 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.2 | 0.8 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 1.7 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.2 | 1.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.2 | 1.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 1.0 | GO:0032262 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
0.2 | 0.6 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.2 | 1.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.6 | GO:0003416 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 4.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 1.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 5.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 1.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 6.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 1.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 5.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 16.5 | GO:0006790 | sulfur compound metabolic process(GO:0006790) |
0.2 | 5.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 0.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 191.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.7 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
0.1 | 2.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 2.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.7 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 1.0 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 1.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 2.0 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 1.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.9 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.9 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 3.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 1.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.3 | GO:0048538 | thymus development(GO:0048538) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.4 | 228.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
23.1 | 69.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
14.5 | 101.4 | GO:0005579 | membrane attack complex(GO:0005579) |
11.1 | 44.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
10.8 | 86.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
10.3 | 31.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
10.2 | 203.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
9.6 | 47.8 | GO:0097413 | Lewy body(GO:0097413) |
9.5 | 56.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
9.2 | 46.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
8.7 | 26.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
8.4 | 33.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
7.8 | 31.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
7.5 | 7.5 | GO:0071914 | prominosome(GO:0071914) |
7.1 | 35.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
6.9 | 34.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
5.3 | 15.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
5.0 | 80.8 | GO:0070852 | cell body fiber(GO:0070852) |
5.0 | 20.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
4.6 | 18.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
4.5 | 31.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
4.2 | 20.9 | GO:1990769 | proximal neuron projection(GO:1990769) |
4.1 | 28.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
4.0 | 425.0 | GO:0072562 | blood microparticle(GO:0072562) |
3.8 | 3.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
3.6 | 32.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
3.3 | 9.9 | GO:0061474 | phagolysosome membrane(GO:0061474) |
3.1 | 21.7 | GO:0090543 | Flemming body(GO:0090543) |
2.8 | 11.3 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
2.8 | 183.6 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
2.7 | 136.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
2.7 | 8.0 | GO:0032398 | MHC class Ib protein complex(GO:0032398) |
2.6 | 13.1 | GO:1903767 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
2.6 | 13.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.5 | 12.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
2.5 | 30.0 | GO:0031983 | vesicle lumen(GO:0031983) |
2.5 | 222.5 | GO:0031526 | brush border membrane(GO:0031526) |
2.4 | 167.4 | GO:0005811 | lipid particle(GO:0005811) |
2.4 | 165.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
2.3 | 18.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
2.3 | 9.2 | GO:0036156 | inner dynein arm(GO:0036156) |
2.3 | 189.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
2.3 | 13.5 | GO:0097422 | tubular endosome(GO:0097422) |
2.2 | 6.6 | GO:0035838 | growing cell tip(GO:0035838) |
2.2 | 38.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
2.1 | 166.0 | GO:0005903 | brush border(GO:0005903) |
2.1 | 6.2 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
2.0 | 6.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.0 | 16.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.0 | 6.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.0 | 9.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.9 | 31.0 | GO:0045180 | basal cortex(GO:0045180) |
1.8 | 18.3 | GO:0002177 | manchette(GO:0002177) |
1.8 | 7.2 | GO:1990005 | granular vesicle(GO:1990005) |
1.7 | 10.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.7 | 45.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.7 | 20.0 | GO:0005861 | troponin complex(GO:0005861) |
1.6 | 4.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
1.6 | 9.5 | GO:0033269 | internode region of axon(GO:0033269) |
1.6 | 22.1 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.6 | 1114.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
1.5 | 6.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.5 | 21.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.4 | 37.4 | GO:0045120 | pronucleus(GO:0045120) |
1.4 | 4.1 | GO:0071942 | XPC complex(GO:0071942) |
1.4 | 9.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.4 | 4.1 | GO:0070421 | DNA ligase III-XRCC1 complex(GO:0070421) |
1.3 | 6.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.3 | 3.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.2 | 9.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.2 | 4.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.2 | 4.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.2 | 1.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.1 | 31.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
1.1 | 10.2 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 2.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
1.1 | 10.7 | GO:0044754 | autolysosome(GO:0044754) |
1.1 | 24.4 | GO:0042588 | zymogen granule(GO:0042588) |
1.1 | 53.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.1 | 9.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.1 | 12.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.0 | 1400.0 | GO:0005615 | extracellular space(GO:0005615) |
1.0 | 9.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 318.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.0 | 17.7 | GO:0030057 | desmosome(GO:0030057) |
1.0 | 2.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.0 | 3.9 | GO:0072487 | MSL complex(GO:0072487) |
0.9 | 3.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.9 | 5.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 27.8 | GO:0005902 | microvillus(GO:0005902) |
0.9 | 1.8 | GO:0055087 | Ski complex(GO:0055087) |
0.9 | 6.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 11.0 | GO:0031362 | intrinsic component of external side of plasma membrane(GO:0031233) anchored component of external side of plasma membrane(GO:0031362) |
0.8 | 5.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.8 | 4.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.8 | 18.8 | GO:0008305 | integrin complex(GO:0008305) |
0.8 | 4.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.8 | 4.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.8 | 6.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 3.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 9.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 10.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.7 | 1.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.7 | 4.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 27.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.7 | 3.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.6 | 3.9 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 4.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 16.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.6 | 4.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.6 | 9.3 | GO:0042611 | MHC protein complex(GO:0042611) |
0.6 | 15.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 4.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.6 | 11.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.6 | 3.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.6 | 1.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 2.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 136.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.6 | 2.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.6 | 18.0 | GO:0005604 | basement membrane(GO:0005604) |
0.5 | 3.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 4.7 | GO:0032009 | early phagosome(GO:0032009) |
0.5 | 77.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.5 | 22.6 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 83.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.5 | 9.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.5 | 9.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 7.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 3.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 792.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.4 | 5.4 | GO:0000801 | central element(GO:0000801) |
0.4 | 3.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.4 | 13.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 3.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 2.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.4 | 1.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.3 | 3.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 27.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 4.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 1.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 67.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 2.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 8.1 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 2.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 47.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 1.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 4.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 1.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 3.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.8 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 47.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 1.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 1.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
48.4 | 145.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
41.6 | 124.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
30.0 | 120.0 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
25.2 | 75.7 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
25.0 | 200.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
22.4 | 67.2 | GO:0008405 | arachidonic acid 11,12-epoxygenase activity(GO:0008405) |
22.1 | 88.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
21.9 | 218.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
21.7 | 21.7 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
21.3 | 85.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
20.1 | 823.8 | GO:0070330 | aromatase activity(GO:0070330) |
19.6 | 58.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
19.5 | 58.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
19.3 | 19.3 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
18.5 | 129.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
18.3 | 165.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
17.2 | 51.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
17.1 | 68.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
16.9 | 50.7 | GO:0008458 | carnitine O-octanoyltransferase activity(GO:0008458) O-octanoyltransferase activity(GO:0016414) |
15.3 | 61.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
15.3 | 45.8 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
15.2 | 45.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
14.7 | 88.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
14.6 | 73.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
14.5 | 43.5 | GO:0098603 | selenol Se-methyltransferase activity(GO:0098603) |
14.0 | 181.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
13.2 | 39.7 | GO:0031714 | C5a anaphylatoxin chemotactic receptor binding(GO:0031714) |
13.0 | 25.9 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
12.8 | 38.3 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
12.7 | 51.0 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
12.6 | 75.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
11.9 | 47.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
11.7 | 46.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
11.6 | 92.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
11.3 | 56.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
11.1 | 77.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
11.0 | 65.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
10.6 | 74.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
10.4 | 135.1 | GO:0005542 | folic acid binding(GO:0005542) |
10.0 | 50.1 | GO:0005534 | galactose binding(GO:0005534) |
9.8 | 49.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
9.7 | 38.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
9.5 | 28.4 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
9.4 | 46.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
9.4 | 37.5 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
9.3 | 130.4 | GO:0015250 | water channel activity(GO:0015250) |
9.3 | 27.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
9.2 | 46.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
9.1 | 45.5 | GO:0004103 | choline kinase activity(GO:0004103) |
9.1 | 18.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
9.0 | 44.9 | GO:0035473 | lipase binding(GO:0035473) |
8.6 | 51.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
8.4 | 33.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
8.2 | 32.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
8.2 | 40.9 | GO:0019862 | IgA binding(GO:0019862) |
7.9 | 31.5 | GO:0030283 | testosterone dehydrogenase [NAD(P)] activity(GO:0030283) |
7.7 | 23.1 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
7.6 | 235.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
7.4 | 140.0 | GO:0001848 | complement binding(GO:0001848) |
7.4 | 36.8 | GO:0005550 | pheromone binding(GO:0005550) |
7.2 | 78.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
7.1 | 28.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
6.7 | 193.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
6.6 | 26.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
6.5 | 45.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
6.4 | 38.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
6.4 | 102.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
6.3 | 12.7 | GO:0001847 | opsonin receptor activity(GO:0001847) |
6.2 | 18.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
6.2 | 87.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
6.1 | 18.4 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
6.0 | 24.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
6.0 | 138.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
6.0 | 47.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
5.9 | 23.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
5.9 | 23.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
5.9 | 29.5 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
5.9 | 52.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
5.8 | 40.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
5.6 | 50.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
5.5 | 38.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
5.4 | 21.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
5.4 | 16.1 | GO:0008142 | oxysterol binding(GO:0008142) |
5.3 | 26.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
5.3 | 154.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
5.3 | 15.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
5.2 | 15.7 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
5.2 | 67.1 | GO:0070402 | NADPH binding(GO:0070402) |
5.1 | 45.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
4.9 | 122.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
4.9 | 19.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
4.8 | 38.7 | GO:0008430 | selenium binding(GO:0008430) |
4.8 | 38.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
4.6 | 9.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
4.6 | 13.7 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
4.5 | 13.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
4.4 | 22.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
4.4 | 13.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
4.4 | 30.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
4.3 | 25.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
4.3 | 12.8 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
4.2 | 25.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
4.2 | 25.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
4.0 | 170.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
4.0 | 31.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
4.0 | 11.9 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
3.9 | 47.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
3.9 | 15.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
3.9 | 11.6 | GO:0019807 | aspartoacylase activity(GO:0019807) |
3.9 | 11.6 | GO:0004359 | glutaminase activity(GO:0004359) |
3.8 | 433.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
3.8 | 15.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.8 | 7.6 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
3.8 | 45.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
3.8 | 22.7 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
3.8 | 11.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
3.7 | 11.1 | GO:0046911 | metal chelating activity(GO:0046911) |
3.7 | 14.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
3.7 | 25.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
3.6 | 14.6 | GO:0004064 | arylesterase activity(GO:0004064) |
3.6 | 10.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
3.5 | 10.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
3.5 | 31.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
3.5 | 17.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
3.5 | 38.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
3.4 | 13.8 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
3.4 | 20.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
3.4 | 174.6 | GO:0038024 | cargo receptor activity(GO:0038024) |
3.3 | 20.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
3.3 | 727.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
3.3 | 39.5 | GO:0019864 | IgG binding(GO:0019864) |
3.3 | 71.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
3.2 | 9.6 | GO:0002060 | purine nucleobase binding(GO:0002060) purine-nucleoside phosphorylase activity(GO:0004731) |
3.2 | 9.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
3.2 | 6.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
3.2 | 9.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
3.1 | 34.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
3.1 | 61.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
3.0 | 9.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
2.9 | 58.7 | GO:0008199 | ferric iron binding(GO:0008199) |
2.9 | 8.8 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
2.9 | 34.8 | GO:0010181 | FMN binding(GO:0010181) |
2.9 | 20.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
2.8 | 19.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
2.8 | 11.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
2.8 | 22.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.8 | 16.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
2.7 | 18.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
2.7 | 13.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.7 | 45.8 | GO:0015643 | toxic substance binding(GO:0015643) |
2.7 | 8.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
2.6 | 7.9 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
2.6 | 13.1 | GO:0033041 | sweet taste receptor activity(GO:0033041) |
2.6 | 2.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.6 | 15.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
2.6 | 10.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
2.5 | 10.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.5 | 46.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
2.4 | 12.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.4 | 24.0 | GO:0015923 | mannosidase activity(GO:0015923) |
2.4 | 23.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.4 | 9.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.3 | 9.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
2.3 | 86.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
2.2 | 13.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
2.2 | 6.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
2.2 | 33.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.2 | 19.6 | GO:0070061 | fructose binding(GO:0070061) |
2.1 | 43.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
2.1 | 10.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
2.1 | 8.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
2.0 | 14.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
2.0 | 42.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
2.0 | 6.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.0 | 9.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
2.0 | 5.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.9 | 7.7 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
1.9 | 5.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.8 | 14.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.8 | 16.6 | GO:0008494 | translation activator activity(GO:0008494) |
1.8 | 14.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.8 | 14.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.8 | 5.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.8 | 8.8 | GO:0031419 | cobalamin binding(GO:0031419) |
1.8 | 28.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.8 | 12.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.7 | 5.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
1.7 | 38.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.7 | 6.9 | GO:0008265 | Mo-molybdopterin cofactor sulfurase activity(GO:0008265) |
1.7 | 5.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
1.7 | 5.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.7 | 5.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
1.7 | 6.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
1.6 | 8.2 | GO:0051373 | FATZ binding(GO:0051373) |
1.6 | 8.2 | GO:1990254 | keratin filament binding(GO:1990254) |
1.6 | 24.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.6 | 21.0 | GO:0098919 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of postsynaptic density(GO:0098919) |
1.6 | 6.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.6 | 8.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.6 | 12.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.6 | 15.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.6 | 4.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.5 | 3.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.5 | 6.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.5 | 7.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.5 | 1.5 | GO:0042806 | fucose binding(GO:0042806) |
1.4 | 7.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.4 | 18.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
1.4 | 11.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.4 | 6.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.4 | 5.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
1.3 | 4.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.3 | 5.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.3 | 6.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.3 | 10.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.3 | 5.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.2 | 3.7 | GO:0031770 | growth hormone-releasing hormone receptor binding(GO:0031770) |
1.2 | 3.7 | GO:0032142 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
1.2 | 16.1 | GO:0003796 | lysozyme activity(GO:0003796) |
1.2 | 8.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.2 | 8.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) |
1.2 | 22.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
1.2 | 41.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.2 | 13.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.2 | 3.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.2 | 72.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
1.2 | 8.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.2 | 5.9 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
1.2 | 3.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.2 | 9.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.1 | 19.5 | GO:0008483 | transaminase activity(GO:0008483) |
1.1 | 3.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 20.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.1 | 5.5 | GO:0015093 | iron ion transmembrane transporter activity(GO:0005381) ferrous iron transmembrane transporter activity(GO:0015093) |
1.1 | 6.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
1.0 | 9.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.0 | 6.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.0 | 4.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.0 | 126.9 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
1.0 | 47.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
1.0 | 46.2 | GO:0051213 | dioxygenase activity(GO:0051213) |
1.0 | 8.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.0 | 11.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 11.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.9 | 6.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.9 | 16.3 | GO:0005522 | profilin binding(GO:0005522) |
0.9 | 3.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 4.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.9 | 13.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.9 | 2.6 | GO:0070698 | nodal binding(GO:0038100) type I activin receptor binding(GO:0070698) |
0.9 | 12.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.9 | 1.7 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.8 | 2.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.8 | 5.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.8 | 6.6 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.8 | 10.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.8 | 8.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.8 | 2.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 6.3 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.8 | 7.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.8 | 3.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 35.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.8 | 3.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 3.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.8 | 3.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.8 | 2.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.8 | 15.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.7 | 3.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 14.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.7 | 2.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 31.0 | GO:0070888 | E-box binding(GO:0070888) |
0.7 | 28.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.7 | 2.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 4.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 5.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.7 | 8.7 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.7 | 4.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.7 | 17.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.7 | 2.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.7 | 9.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 37.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.6 | 3.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 6.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 10.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.6 | 1.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.6 | 3.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.6 | 2.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 8.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.6 | 7.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.6 | 4.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.6 | 1.7 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.6 | 4.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 2.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 4.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 45.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.5 | 2.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 31.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 1.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.5 | 3.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 6.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 87.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.5 | 3.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 7.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.5 | 14.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.5 | 3.9 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.5 | 5.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 2.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 20.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.5 | 11.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.5 | 3.3 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.5 | 0.9 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.5 | 19.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.5 | 3.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.5 | 5.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 2.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 8.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 4.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 94.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.4 | 0.8 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 1.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 9.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.4 | 2.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 12.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 3.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 2.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 4.6 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 2.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 3.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 2.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 11.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 17.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.3 | 1.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 2.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 1.6 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 3.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 3.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 12.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 12.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 1.2 | GO:0001635 | calcitonin gene-related peptide receptor activity(GO:0001635) |
0.3 | 8.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.3 | 2.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 2.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 5.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 4.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 7.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 2.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 31.5 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 12.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.7 | GO:0019809 | spermidine binding(GO:0019809) |
0.2 | 2.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 5.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 3.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 2.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 5.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 2.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 12.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 1.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 3.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 3.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.6 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.2 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 3.0 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.2 | 1.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 191.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 5.9 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 1.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 33.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 12.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 1.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 4.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 1.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.6 | 297.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
8.0 | 440.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
5.1 | 75.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.7 | 129.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
2.6 | 46.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
2.1 | 497.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
2.0 | 32.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.8 | 19.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.7 | 32.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.7 | 11.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.6 | 32.9 | PID EPO PATHWAY | EPO signaling pathway |
1.5 | 7.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.5 | 49.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.5 | 10.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.5 | 43.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.4 | 44.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.4 | 76.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.4 | 38.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.4 | 50.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.4 | 18.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.3 | 10.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.0 | 6.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 37.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.9 | 56.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.8 | 3.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.8 | 27.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 19.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.7 | 14.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.7 | 19.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 32.3 | PID BMP PATHWAY | BMP receptor signaling |
0.6 | 2.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.6 | 38.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 10.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 10.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 7.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 26.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 4.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 11.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 30.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.6 | 9.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 2.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 2.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 12.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 19.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 5.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 13.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 19.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 5.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 2.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 1.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 11.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 2.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 16.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 7.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 38.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 2.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 4.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 16.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 3.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.0 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 2.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.8 | 83.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
19.5 | 194.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
15.2 | 136.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
14.2 | 241.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
13.4 | 255.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
12.4 | 148.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
11.9 | 178.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
11.7 | 105.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
11.3 | 202.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
11.0 | 143.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
10.2 | 295.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
9.6 | 115.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
8.9 | 168.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
8.7 | 183.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
6.8 | 60.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
6.6 | 256.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
6.4 | 6.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
6.3 | 69.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
5.8 | 46.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
5.2 | 67.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
5.1 | 50.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
4.9 | 791.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
4.9 | 44.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
4.6 | 41.0 | REACTOME DEFENSINS | Genes involved in Defensins |
4.4 | 35.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
3.3 | 36.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
3.2 | 45.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.1 | 90.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
3.0 | 24.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
3.0 | 41.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
3.0 | 98.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
2.9 | 11.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.6 | 20.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
2.5 | 29.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.4 | 9.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
2.4 | 47.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.3 | 32.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
2.3 | 22.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
2.3 | 36.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
2.2 | 60.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
2.1 | 41.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
2.0 | 14.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
2.0 | 54.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
2.0 | 6.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
2.0 | 67.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.9 | 14.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.7 | 39.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.6 | 91.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.6 | 20.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.5 | 12.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.5 | 16.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.5 | 22.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.5 | 22.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.5 | 20.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.4 | 46.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.3 | 22.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 14.3 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
1.3 | 89.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.3 | 24.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.2 | 29.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.2 | 7.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.1 | 15.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.1 | 39.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.1 | 13.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.1 | 24.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.1 | 11.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.0 | 14.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.0 | 15.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.9 | 7.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.9 | 11.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.8 | 15.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.8 | 34.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.8 | 7.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.8 | 5.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.7 | 8.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 33.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.7 | 3.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.7 | 3.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.7 | 14.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.7 | 7.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.7 | 6.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.6 | 14.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 39.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.6 | 14.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 8.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.6 | 23.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 13.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 37.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 10.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 5.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 2.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.5 | 10.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 22.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 4.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.5 | 10.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 5.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 16.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 5.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.4 | 6.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 3.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 18.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.3 | 3.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 29.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 4.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 10.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 20.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 2.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.3 | 6.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 2.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 11.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 4.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 2.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.0 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 1.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 2.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 4.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 2.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 5.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 3.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 4.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.6 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |